11.11.2009 • News

Arch Chemicals Q2 Profit Slips

Arch Chemicals said that second-quarter profit fell as lower volumes and unfavourable foreign exchange rates offset higher pricing and the favorable impact of the Advantis acquisition. Net earnings declined to $30.9 million, or $1.23 per share, from $33.2 million, or $1.33 per share, a year earlier, the Norwalk, Connecticut-based company said. Revenue fell to $414.2 million from $469.6 million.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.